Skip to main content
Premium Trial:

Request an Annual Quote

Plus Five

The US National Institute of Health's National Center for Advancing Translational Science has announced that five more pharmaceutical companies have joined its program to find new uses for early-stage drugs that did not make it through the full pipeline, reports ScienceInsider's Jocelyn Kaiser. This expansion brings the number of compounds NCTAS is testing to 58, she adds. Abbott Laboratories, Bristol-Myers Squibb, GlaxoSmithKline, Sanofi, and Janssen Pharmaceuticals are joining the initial three partners, Pfizer, AstraZeneca, and Eli Lilly. The jury is still out on whether the program will accomplish its stated goals — some pharma experts are skeptical, while others think there is potential, but are worried that the legal agreements between the companies and the academics doing the research are unclear, Kaiser says.

Daily Scan's sister publication GenomeWeb Daily News has more here.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.